The multifaceted effects of fluoxetine treatment on cognitive functions
Frontiers in Pharmacology · 16.07.2024 · 15
DOI: 10.3389/fphar.2024.1412420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.07.2024. Verfasst von Estíbaliz Ampuero und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Neurofarmacología del Comportamiento, Facultad de Química y Biología, Universidad de Santiago, Santiago, Chile. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fluoxetine, the prototypical selective serotonin reuptake inhibitor (SSRI), is widely used to treat major depressive disorder (MDD) and a variety of other central nervous system conditions, primarily due to its established clinical safety profile. Although its efficacy in treating depression is well-recognized, the impact of fluoxetine on cognitive functions remains inconsistent and elusive. In this review, we first examine the well-substantiated biological mechanisms underlying fluoxetine’s antidepressant effects, which include serotonin reuptake inhibition and activation of TrkB receptors—key to brain-derived neurotrophic factor (BDNF) signaling. Subsequently, we delve into the cognitive side effects observed in both preclinical and clinical studies, affecting domains such as memory, attention, and executive functions. While certain studies indicate cognitive improvements in patients with underlying disorders, there is also evidence of negative effects, influenced by variables like gender, duration of treatment, age, disease pathology, and the specifics of cognitive testing. Significantly, the negative cognitive outcomes reported in preclinical research often involve healthy, non-diseased animals. This review underscores the necessity for heightened caution in fluoxetine prescription and further investigation into its potentially detrimental cognitive effects, even when used prophylactically.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio Neurofarmacología del Comportamiento, Facultad de Química y Biología, Universidad de Santiago, Santiago, Chile.
- Laboratorio Neurociencias, Facultad de Medicina, Universidad de los Andes, Santiago, Chile.
- IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile.
Zitieren
APA
Ampuero, E., Luarte, A., Flores, F. S., Soto, A. I., Pino, C., Silva, V., Erlandsen, M., Concha, T., & Wyneken, U. (2024). The multifaceted effects of fluoxetine treatment on cognitive functions. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1412420
Vancouver
Ampuero E, Luarte A, Flores FS, Soto AI, Pino C, Silva V, et al. The multifaceted effects of fluoxetine treatment on cognitive functions. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1412420
BibTeX
@article{Ampuero2024,
author = {Ampuero, Estíbaliz and Luarte, Alejandro and Flores, Francisca Sofia and Soto, Antonia Ignacia and Pino, Catalina and Silva, Viviana and Erlandsen, Macarena and Concha, Teresita and Wyneken, Ursula},
title = {The multifaceted effects of fluoxetine treatment on cognitive functions},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1412420}
}
EUVIMED